首页 | 本学科首页   官方微博 | 高级检索  
     

静脉溶栓序贯给药法对急性心肌梗塞冠脉再通疗效的观察
引用本文:钟尹元 张云. 静脉溶栓序贯给药法对急性心肌梗塞冠脉再通疗效的观察[J]. 现代诊断与治疗, 1996, 7(5): 275-277
作者姓名:钟尹元 张云
作者单位:山东聊城地区第二医院
摘    要:目的观察静脉溶栓序贯给药法对急性心肌梗塞早期冠脉再通的疗效。方法205例AMI患者随机分成序贯组(溶栓前肝素-尿激酶-溶栓后肝素)107例,和对照组(98例)。尿激酶溶栓前序贯组先用肝素5000U,而对照组只用安慰剂(尿激酶-肝素)。结果序贯组的早期冠脉再通率明显高于对照组,分别为71.03%和52.04%,P<0.01,前者的ST段回落和T波反转也明显快于后者。两组出血并发症相似。结论静脉溶栓序贯给药法明显提高早期冠脉再通率而不增加出血危险性。

关 键 词:急性心肌梗塞  肝素尿激酶

Effect of Sequential Usage of Intravenous Thrombolysis on Coronary Patency in Acute Myocardial Infarction
Zhong Yinyuan,Zhang Yun,Sun Yanqin,Li Junfang. Effect of Sequential Usage of Intravenous Thrombolysis on Coronary Patency in Acute Myocardial Infarction[J]. Modern Diagnosis & Treatment, 1996, 7(5): 275-277
Authors:Zhong Yinyuan  Zhang Yun  Sun Yanqin  Li Junfang
Abstract:Objective To Study the effect of a sequential usage of intravenous thrombolysis(pre thrombolytic heparin urokinase postthrombolytic heparin) on early coronary patency in patients with acute myocardial infarction. Method The 205 patients were divided into two groups randomly. The sequential group of 107 cases were treated with heparin (5000U) urokinase posttromb*lytic h*parin. 98 cases as control group were given only placebo urokinase heparin. Results The early coronary patency rate was higher in the sequential group than in the control group (71.03% and 52.04% respectively, P<0.01). The fall after rise of ST segment and T wave inversion were far earlier in the former group than in the latter (P<0.005).Bleeding complications were similar between the two groups. Conclusion The sequential usage of intravenous thrombolysis improves the rate of early coronary patency obviovsly, and doesn’t increase the risk of bleeding.
Keywords:Acute myocardial infarction Heparin Urokinase  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号